SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-020389
Filing Date
2023-03-16
Accepted
2023-03-15 20:41:26
Documents
3
Period of Report
2023-03-16

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea175309-6k_alterity.htm 6-K 17283
2 FIRST PATIENT ENROLLED IN USA IN PHASE II CLINICAL TRIAL ea175309ex99-1_alterity.htm EX-99.1 14407
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4231
  Complete submission text file 0001213900-23-020389.txt   38758
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 23736827
SIC: 2834 Pharmaceutical Preparations